Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities ...

With the pharmaceutical industry aiming to grow from $58 billion to $130 billion by 2030, he highlighted significant ...

PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

Get a Free Sample PDF copy of the report @- The global mouthwash market is witnessing robust growth, fueled by increasing consumer awareness regarding dental health and the need for convenient oral ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...

North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...